| Bioactivity | AC-178335 is a SRIF antagonist, with a Ki of 172 nM. AC-178335 blocks SRIF inhibition of adenylate cyclase in vitro (IC50=5.1 μM). AC-178335 induces GH release in anesthetized rats[1]. |
| CAS | 212966-15-9 |
| Sequence | Ac-{d-(His-Phe-Ile-Arg-Trp-Phe)}-NH2 |
| Shortening | Ac-{d-(HFIRWF)}-NH2 |
| Formula | C49H63N13O7 |
| Molar Mass | 946.11 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Baumbach WR, et, al. A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. Mol Pharmacol. 1998 Nov;54(5):864-73. |
AC-178335
CAS: 212966-15-9 F: C49H63N13O7 W: 946.11
AC-178335 is a SRIF antagonist, with a Ki of 172 nM. AC-178335 blocks SRIF inhibition of adenylate cyclase in vitro (IC5
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.